The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

16 Apr 2020 15:45

RNS Number : 9348J
Medica Group PLC
16 April 2020
 

Medica Group PLC

 

Director / PDMR Shareholding

 

Medica Group PLC (the "Company") announces that on 15 April 2020, the PDMRs listed below were granted options over ordinary shares of 0.2p each in the Company under the Company's Deferred Bonus Plan 2017 at a nil exercise price:

 

Name of PDMR

Number of shares subject to option

Stuart Quin

 

2,564

Anthony Lee

 

3,167

Dr Stephen Davies

 

4,525

 

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation, and set out more details of the transactions.

 

1.

Details of PDMR

(a)

Name

1. Stuart Quin

2. Anthony Lee

3. Dr Stephen Davies

 

2.

Reason for notification

(b)

Position / status

1. Chief Executive Officer

2. Chief Financial Officer

3. Medical Director and Responsible Officer

 

(c)

Initial notification / amendment

Initial notification in each case

3.

Details of the Issuer

(a)

Name

Medica Group PLC

(b)

LEI

213800B8XE5FUSZF5Z16

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted

(a)

Description of the financial instrument

Ordinary shares of 0.2p each in the capital of the Company ("Shares")

(b)

Nature of the transaction

Grant of options to acquire Shares pursuant to the Company's Deferred Bonus Plan 2017

(c)

Price(s) and volume

Option Price nil in each case

1. 2,564

2. 3,167

3. 4,525

 

(d)

Aggregated information

N/A

(e)

Date of the transaction

15 April 2020

(f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKKABNQBKDQQD

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.